Koninklijke Philips (PHG) Projected to Post Quarterly Earnings on Wednesday

Koninklijke Philips (NYSE:PHG) is expected to post its quarterly earnings results before the market opens on Wednesday, February 19th. Analysts expect Koninklijke Philips to post earnings of $0.55 per share and revenue of $5.10 billion for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Koninklijke Philips Trading Down 1.6 %

Shares of PHG stock opened at $28.16 on Tuesday. Koninklijke Philips has a fifty-two week low of $19.55 and a fifty-two week high of $32.91. The stock has a market cap of $26.47 billion, a P/E ratio of -67.04, a P/E/G ratio of 0.90 and a beta of 0.77. The business has a fifty day simple moving average of $26.21 and a 200-day simple moving average of $28.20. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on PHG. StockNews.com lowered Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th. Jefferies Financial Group raised Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Koninklijke Philips currently has a consensus rating of “Hold”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.